A joint effort by National Jewish Health and Icahn School of Medicine at Mount Sinai, The Respiratory Institute will provide comprehensive care to patients in New York City while furthering national respiratory research, beginning October 1st.
An International Trade Commission judge ruled last week that 9 products from BMC Medical Co Ltd, a Chinese company, infringe on ResMed patents.
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily ICS for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older.
A new therapeutic drug, GAL-021, may reverse or prevent respiratory depression, or inadequate breathing, in patients taking opioid medication without compromising pain relief or increasing sedation.
AstraZeneca has launched a Phase III test of its targeted IL-13 asthma drug tralokinumab but will face heavyweight competition in the clinic from Roche.
A study tracked how language that first appeared in tobacco industry’s submissions gradually crept into the final drafts of the European tobacco directive.
CHRISTUS Health (Dallas) will start using Nellcor pulse oximetry technology from Covidien to improve patient safety.
Although long-term health effects of e-cigarette use are unknown, compared with conventional cigarettes they are likely to be much less harmful to users or bystanders, according to researchers at Queen Mary University of London.
A researcher has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
US News & World Report released the 25th edition of the annual Best Hospitals rankings. For the first time, the Mayo Clinic in Rochester, Minn, claimed the number 1 spot.